Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Anemia 4 Neoplasms 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Hematologic Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Transfusion Reaction 1 Thalassemia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Patient Participation 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Hemorrhage 1 Carcinoma, Non-Small-Cell Lung 1 Bronchiolitis Obliterans Syndrome 1 Bone Marrow Failure Disorders 1 Anemia, Sickle Cell 1 Anemia, Aplastic 1

Interventions

fludarabine 4 fludarabine phosphate 3 Cyclophosphamide 3 AP 1903 reagent 2 thymoglobulin 1 ruxolitinib 1 Whole-Body Irradiation 1 Thiotepa 1 Tacrolimus 1 Rituximab 1 Peripheral Blood Stem Cell Transplantation 1 Panobinostat 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Erythrocyte Count 1 Dexamethasone 1 Clofarabine 1 Busulfan 1 Bortezomib 1 Blood Transfusion 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Thalassemia × Blood Transfusion × Clear all

NCT05255445 2024-05-17

RBC-IMPACT

Westat

Classical hematology

Anemia, Sickle Cell, Neoplasms, Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡